Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gajus Worthington, Samuel Colella

Premium

Fluidigm has re-elected Gajus Worthington and Samuel Colella to serve as class III directors until the firm's 2016 stockholder meeting.

Colella, who is a managing director of Versant Ventures, has been a member and chairman of the company's board since 2000.

Worthington is the company's president, CEO, and co-founder, and he has been a director since the firm launched in 1999.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.